purine has been researched along with Bile Duct Cancer in 1 studies
1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Q | 1 |
| Lin, M | 1 |
| Feng, X | 1 |
| Ma, F | 1 |
| Zhu, Y | 1 |
| Liu, X | 1 |
| Qu, C | 1 |
| Sui, H | 1 |
| Sun, B | 1 |
| Zhu, A | 1 |
| Zhang, H | 1 |
| Huang, H | 1 |
| Gao, Z | 1 |
| Zhao, Y | 1 |
| Sun, J | 1 |
| Bai, Y | 1 |
| Jin, J | 1 |
| Hong, X | 1 |
| Zou, C | 1 |
| Zhang, Z | 1 |
1 other study available for purine and Bile Duct Cancer
| Article | Year |
|---|---|
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism.
Topics: Amino Acid Substitution; Bile Duct Neoplasms; Cell Line, Tumor; Cellular Reprogramming; Cholangiocar | 2020 |